Postganglionic sympathetic nerve terminals innervate cardiac muscle and express opioid receptor-like 1 (ORL1) receptors, the most recently described member of the opioid receptor subclass. ORL1 receptors are stimulated by the endogenous heptadecapeptide nociceptin (Noc). To better understand how the signaling events by Noc regulate sympathetic neuron excitability, the goal of the present study was to determine whether sympathetic stellate ganglion (SG) neurons, innervating the heart, natively express ORL1 opioid receptors and couple to Ca 2ϩ channels. SG neurons in adult male rats were retrograde-labeled with a fluorescent tracer via injection of the ventricular muscle employing ultrasound imaging. Thereafter, N-type Ca 2ϩ channel modulation was investigated using the whole-cell variant of the patch-clamp technique. Exposure of labeled SG neurons to Noc resulted in a concentration-dependent inhibition of Ca 2ϩ currents (with an estimated EC 50 of 193 Ϯ 14 nM). Pre-exposure of SG neurons to the ORL1 receptor blocker, [Nphe 1 ,Arg 14 ,Lys 15 ]N/OFQ-NH 2 (UFP-101), significantly decreased the Noc-mediated Ca 2ϩ current inhibition. The Ca 2ϩ current inhibition was also blocked by pertussis toxin pretreatment, indicating that signaling occurs via G␣ i/o G proteins. Finally, the full-length ORL1 receptor cDNA in SG neurons was cloned and sequenced. Of the two known alternatively spliced variants in rats, sequencing analysis showed that the ORL1 receptor expressed in SG neurons is the short form. Overall, these results suggest that stimulation of postsynaptic ORL1 receptors by Noc in SG neurons regulate cardiac sympathetic activity.
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The opioid receptor-like 1 (ORL1) receptor and the three "classic" opioid receptor subtypes (, , and ␦) are members of the G protein-coupled receptor superfamily. The heptadecapeptide nociceptin, (Noc, also known as orphanin/FQ) is the endogenous ORL1 receptor ligand. ORL1 receptors are coupled to members of the pertussis toxin (PTX)-sensitive G␣ i/o G protein family. Stimulation of ORL1 receptors by Noc results in inhibition of voltage-gated Ca 2ϩ channels, activation of G protein-gated inwardly rectifying K ϩ channels, and negative coupling to adenylyl cyclases (for review, see New and Wong, 2002) .
Although the ORL1 receptor-nociceptin system is known to be involved in pain transmission in the central nervous system (Meunier et al., 2000) , recent evidence has shown that opioid receptors are widely distributed in the peripheral nervous system and are capable of eliciting potent cardiovascular responses (for review, see Kapusta, 2000; Malinowska et al., 2002) . Noc, for example, evokes a decrease in arterial blood pressure and heart rate when administered intracerebroventricularly, intrathecally, or intravenously (Giuliani et al., , 2000 Salis et al., 2000; Hashiba et al., 2003) . Noc has also been found to exert an inhibitory neuromodulation on transmitter release in the heart ) and blood vessels (Bucher, 1998; Malinowska et al., 2000) . These studies suggest that the presence of ORL1 receptors in the central and peripheral nervous systems regulate cardiac function by modulating autonomic neurotransmission ]e.g., inhibition of norepinephrine (NE) release].
Increases in both blood pressure and heart rate, observed following electrical stimulation of preganglionic cardiac efferent sympathetic nerve fibers, were inhibited by Noc in a dose-dependent manner (Malinowska et al., 2001 ). This response was shown to occur through the stimulation of ORL1 receptors located presynaptically on the postganglionic sympathetic nerve endings. Postganglionic neurons arising from the stellate ganglion (SG) provide the main sympathetic innervation to the heart and play a significant role in regulating cardiac function (Wallis et al., 1996) . Accordingly, the purpose of the present study was to determine whether SG neurons, innervating cardiac muscle, possess ORL1 receptors and to examine the signal transduction pathways involved in Ca 2ϩ channel modulation. In addition, the identification of the ORL1 receptor splice variant expressed in SG neurons was explored.
Materials and Methods
SG Labeling and Isolation. All experimental procedures performed were approved by the Institutional Animal Care and Use Committee (IACUC) at Penn State College of Medicine and conformed to the guidelines of the National Institutes of Health Guide for the Care and Use of Laboratory Animals. SG neurons were retrograde-labeled employing ultrasound imaging as described previously (Fuller et al., 2004) . Briefly, adult male Wistar rats (225-450 g) were anesthetized with intraperitoneal administration of ketamine HCl (75 mg/kg) and xylazine (5 mg/kg). The heart was ultrasonographically imaged using either a Sonoline Sienna or Sequoia C256 Echocardiography system (Siemens Medical Solutions, Mountain View, CA) equipped with a 7.5 or 14 MHz probe, respectively. Thereafter, under echocardiographic guidance, either True Blue (2.5% in H 2 O; Molecular Probes, Eugene, OR) or DiIC 12 (3) (1,1Ј-didodecyl-3,3,3Ј,3Ј-tetramethylindocarbocyanine perchlorate, 1% in DMSO; Molecular Probes) was injected into the ventricular muscle employing a syringe with a 30-gauge needle. The total volume injected ranged from 50 to 100 l.
Five to 12 days following dye injection, the rats were sacrificed by CO 2 anesthesia and decapitated. The SG was removed and cleared of connective tissue in ice-cold Hanks' balanced salt solution. Thereafter, the SG was incubated for 60 min in a shaking water bath at 35°C in Earle's balanced salt solution with 0.6 mg/ml collagenase Type D (Roche Diagnostics, Indianapolis, IN), 0.4 mg/ml trypsin (Worthington Biochemicals, Freehold, NJ), and 0.1 mg/ml DNase Type I (Sigma-Aldrich, St. Louis, MO). After the incubation period, the cells were dissociated in a culture flask by vigorous shaking, and the dispersed neurons were centrifuged twice for 6 min at 50g and resuspended in minimal essential medium (Invitrogen, Carlsbad, CA) supplemented with 10% fetal calf serum, 1% glutamine, and 1% penicillin-streptomycin solution (Invitrogen). Neurons were then plated into 35-mm tissue culture plates coated with poly-L-lysine and stored in a humidified incubator containing 5% CO 2 in air at 37°C.
Fluorescent images of DiI-labeled neurons were captured with an Orca-ER 1394 cooled CCD camera (Hamamatsu Photonics K.K., Hamamatsu City, Japan) and IPLab software (Scanalytics, Fairfax, VA) on an inverted microscope (TE2000; Nikon, Tokyo, Japan) equipped with an epifluorescence unit and G-2E/C filter set (Nikon) containing an excitation filter at 540 Ϯ 12 nm, a dichroic beam splitter of 565 nm (long pass), and an emission filter at 620 Ϯ 30 nm.
Electrophysiology and Data Analysis. For electrophysiological recordings, labeled cells were identified with an inverted microscope (Diaphot 300; Nikon) equipped with an epifluorescence unit and G-2E/C and UV/2A (excitation filter at 355 Ϯ 25 nm, dichroic mirror cut-on at 400-nm long pass, and emission filter at 420-nm long pass; Nikon) filter cube sets for DiI and True Blue, respectively. Ca 2ϩ currents were recorded at room temperature (21-24°C) employing the whole-cell patch-clamp technique. The pipettes were pulled from borosilicate glass capillaries (Corning 7052; Garner Glass, Claremont, CA) on a Flaming-Brown (P-97) micropipette puller (Sutter Instrument Co., San Rafael, CA), coated with Sylgard (Dow Corning, Midland, MI), and fire polished. Whole-cell currents were acquired with a patch-clamp amplifier (Axopatch 1-C; Axon Instruments, Foster City, CA), analog filtered at 5 to 10 kHz (Ϫ3 dB; 4-pole Bessel), and digitized using custom designed software (S4) on a Power PC computer (Power Computing Corp., Austin, TX) equipped with a 16-bit analog-to-digital converter board (ITC16; InstruTECH Corporation, Port Washington, NY). Cell membrane capacitance and series resistance (80 -85%) were electronically compensated. Data and statistical analyses were performed with the IGOR Pro (Wavemetrics, Lake Oswego, OR) and Prism 4 (GraphPad Software, Inc., San Diego, CA) software packages, respectively. Changes in Ca 2ϩ currents were assessed using a standard t test. P Ͻ 0.05 was considered statistically significant. Graphs and current traces were produced with the IGOR Pro and Canvas (Deneba Software, Miami, FL) software packages.
The pipette solution contained 120 mM N-methyl-D-glucamine, 20 mM tetraethylammonium hydroxide, 11 mM EGTA, 10 mM HEPES, 10 mM sucrose, 1 mM CaCl 2 , 4 mM Mg-ATP, 0.3 mM Na 2 ATP, and 14 mM Tris-creatine phosphate. The pH was adjusted to 7.2 with methanesulfonic acid and HCl (20 mM), and the osmolality was 296 to 302 mOsmol/kg. The external solution consisted of 145 mM tetraethylammonium hydroxide, 10 mM HEPES, 15 mM glucose, 10 mM CaCl 2 , and 0.0003 mM tetrodotoxin. The pH was adjusted to 7.4 with methanesulfonic acid, and the osmolality was 317 to 323 mOsmol/kg.
The concentration-response curve for Noc was determined by sequential application of increasing concentrations of the agonist. To avoid effects of desensitization by Noc, no more than three concentrations were tested in each cell, and electrophysiological recordings from neighboring cells were avoided. In most cases, prior to the end of the recordings, 3 M Noc (e.g., third application) was applied to obtain the maximal Ca 2ϩ current inhibition. In this set of experiments, a sequential application of Noc was not performed until the Ca 2ϩ current amplitude returned to the control value. The results were pooled, and each point represents the mean Ϯ S.E.M. The concentration-response curve was fit to the Hill equation:
n ] where I is the normalized Ca 2ϩ current inhibition, k is a constant, [Noc] is Noc concentration, and n is Hill factor. Solutions and Drugs. Stock solutions of Noc, [D-Ala 2 ]-deltorphin II, U-50488, and endomorphin-1 (all from Tocris Cookson, Ellisville, MO) and vasoactive intestinal peptide (VIP; Phoenix Pharmaceuticals, Belmont, CA) were prepared as stock solutions in H 2 O and diluted to their final concentration just prior to use. PTX (List Biological Laboratories, Inc., Campbell, CA) was prepared in H 2 O and added to the culture medium (12-20 h) at a final concentration of 500 ng/ml. UFP-101, a kind gift from Dr. Giro Calo (University of Ferrara, Ferrara, Italy), was also prepared in H 2 O and applied via the perfusion system at least 10 min before seal formation and maintained for the duration of the experiment. Drug application to the cells under study was performed by placing a custom-designed gravity-fed perfusion system approximately 100 m from the neuron.
Isolation of the Full-Length Rat ORL1 Receptor cDNA. Total RNA was isolated from SG obtained from adult Wistar rats, described above. Thereafter, total RNA was purified with the RNeasy miniprep kit (QIAGEN, Valencia, CA) . Approximately 1 g of total RNA was used to generate oligo(dT) primed first-strand cDNA using the Advantage RT for polymerase chain reaction (PCR) kit (BD Biosciences Clontech, Palo Alto, CA). Primers for the fulllength PCR were generated based on the ORL1 receptor sequence from GenBank account no. NM_031569. The primers used were: 5Ј-GAT CGG ATC CAC CAT GGA GTC CCT CTT TCC TGC TC and 3Ј-GAT CCT CGA GTC ATG CTG GCC GTG GTA CTG TC. The restriction enzyme sites for BamHI and XhoI were added to the Nand C-terminal primers, respectively. The full-length ORL1 receptor PCR product was generated using Pfu Turbo DNA polymerase (Stratagene, La Jolla, CA) and subcloned with the Zero Blunt TOPO PCR Cloning Kit (Invitrogen). Positive clones were sequenced employing BigDye terminators (Applied Biosystems, Foster City, CA) and ABI 377 DNA sequencer (Applied Biosystems). The nucleotide sequence was deposited in GenBank (AY152731).
Results
The purpose of the present study was to examine the functional coupling of Ca 2ϩ channels and ORL1 receptors in SG neurons innervating rat heart muscle. In this subpopulation of neurons, N-type Ca 2ϩ channel subtypes contribute greater than 50% of the total Ca 2ϩ currents in rats (Kukwa et al., 1998; Fuller et al., 2004) . Rat sympathetic SG neurons were retrograde-labeled employing ultrasound-guided dye injection to circumvent surgical procedures (Fuller et al., 2004) . Figure 1 , A and B, shows the phase and fluorescence image of SG neurons acutely dissociated from a rat which had been injected with the fluorescent tracer DiI in the heart 6 days prior to cell isolation. Figure 1B illustrates that one of the three neurons shown has been effectively labeled with DiI.
The initial set of experiments was performed to determine the opioid receptor subtypes expressed in SG neurons. Figure  2A shows the time course of peak Ca 2ϩ current of a labeled SG neuron exposed to three opioid receptor subtype agonists. Traces representing the responses are shown in Fig. 2B . Cells were held at Ϫ80 mV and the test pulse was changed to ϩ10 mV for 50 ms every 10 s. Application of the selective opioid receptor agonist endomorphin-1 (10 M) did not elicit a response from the cell (Fig. 2, A and B) . On the other hand, exposure of 3 M Noc led to approximately a 75% inhibition of Ca 2ϩ currents. Finally, bath application of the opioid receptor agonist U-50488 (10 M) caused a Ca 2ϩ current inhibition of nearly 10% (Fig. 2, A and B) . The summarized results plotted in Fig. 2C also show that the ␦ opioid receptor agonist deltorphin II (2 M) did not lead to significant inhibition of Ca 2ϩ currents. These results suggest that the soma of SG neurons do not natively express the three classic opioid receptors and that a reproducible (all eight neurons tested) and robust inhibitory response of Ca 2ϩ currents can be recorded following Noc exposure.
The next set of experiments was undertaken to determine the concentration-response relationship for Noc-stimulated ORL1 Ca 2ϩ current inhibition in labeled SG neurons. The Ca 2ϩ currents were recorded as described for Fig. 2A . Figure  3 , A and B, illustrates that exposure of 0.03 and 1 M Noc caused a 7 and 75% inhibition of Ca 2ϩ currents, respectively. The Noc concentration-response curve is shown in Fig. 3C . Results are expressed as Ca 2ϩ current inhibition (normalized to 3 M Noc) plotted against log[nociceptin] and then fitted using the Hill equation. The estimated EC 50 was 193 Ϯ 14 nM (n ϭ 3-13 neurons). jpet.aspetjournals.org
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Next, the ability of the selective ORL1 receptor antagonist UFP-101 (Calo et al., 2002) to affect the coupling of Ca 2ϩ channels with ORL1 receptors was tested. Neurons were preincubated for at least 10 min with 10 M UFP-101 prior to Noc (1 M) application. Figure 3D is a summary comparing the Ca 2ϩ current inhibition in cells exposed to either Noc or Noc ϩ UFP-101. Under control conditions, Noc caused a mean Ca 2ϩ current inhibition of 70 Ϯ 3% (S.E.M., n ϭ 4). On the other hand, UFP-101 treatment completely eliminated the Noc-mediated Ca 2ϩ current inhibition to 6 Ϯ 2% (S.E.M., n ϭ 4). The inset in Fig. 3D shows the Ca 2ϩ currents elicited before and after application of Noc ϩ UFP-101.
In this set of experiments, the signaling components involved in ORL1 receptor-mediated Ca 2ϩ channel inhibition were examined. ORL1 receptors typically couple to the PTXsensitive G␣ i/o G protein subfamily. Figure 4A shows the time course of peak Ca 2ϩ currents following application of Noc (3 M) and VIP (10 M). VIP stimulates a G proteincoupled receptor subtype that preferentially couples to the PTX-insensitive G␣ s G protein subfamily (Zhu and Ikeda, 1994) . The inset in Fig. 4A shows the Ca 2ϩ current traces before and after agonist exposure. The Ca 2ϩ current inhibition mediated by Noc and VIP were 64 Ϯ 4% (S.E.M., n ϭ 10) and 54 Ϯ 5% (S.E.M., n ϭ 6), respectively. A separate group of SG neurons was pretreated overnight with PTX, and the time course of peak Ca 2ϩ currents is shown Fig. 4B . The plot and inset show that application of Noc resulted in a small inhibition of Ca 2ϩ currents when compared with control neurons. Conversely, when the neuron was exposed to VIP, Ca 2ϩ current inhibition was similar to that observed in control neurons. Figure 4C is a summary that illustrates PTX pretreatment disrupted the coupling between ORL1 receptors and Ca 2ϩ channels such that the Noc-mediated Ca 2ϩ current inhibition was significantly decreased (P Ͻ 0.05).
Next, we wanted to determine whether the Noc-mediated inhibitory effects on Ca 2ϩ currents occurred in a voltagedependent (VD) manner. N-type Ca 2ϩ channel currents are modulated by various neurotransmitters resulting in "kinetic slowing" of the rising Ca 2ϩ currents during a depolarizing test pulse (for review, see Ikeda and Dunlap, 1999) . The kinetic slowing is thought to be the result of a VD relief of channel block during the test pulse. The VD relief of Ca 2ϩ channel inhibition leads to "facilitation" of Ca 2ϩ currents and can be observed by applying a "double-pulse" voltage protocol (Ikeda, 1991) . Employing this voltage paradigm, Ca 2ϩ current amplitude is measured from the test pulses (ϩ10 mV) occurring after and before the conditioning pulse to ϩ80 mV. One hallmark of VD inhibition is an enhanced postpulse current amplitude. Figure 4D shows superimposed Ca 2ϩ current traces evoked with the double-pulse voltage protocol (shown at the top) before (top trace) and after (bottom trace) Noc (3 M) exposure. In the absence of agonist, it can be seen that the conditioning pulse had a minor effect on the postpulse current amplitude. The presence of a "tonic facilitation" in sympathetic neurons has been shown to result from a small degree of basal G protein activation (Ikeda, 1991; RuizVelasco and Ikeda, 2000) . Following bath application of Noc, the Ca 2ϩ currents displayed both a VD block and kinetic slowing as evidenced by the biphasic rising phase (top trace). It should be mentioned that the conditioning pulse did not fully restore current amplitude in the presence of Noc. This is possibly a result of a voltage-independent modulation of Ca 2ϩ channels and involves second messenger pathways (Ikeda and Dunlap, 1999; Beedle et al., 2004) .
At least two ORL1 receptor splice variants have been reported to be expressed in rat sympathetic (superior cervical and lumbar) and sensory neurons (Xie et al., 1999) . The long variant contains an 84-base pair insertion in the receptor's second extracellular loop domain. This additional sequence contains a putative N-linked glycosylation site. In this set of experiments, we wanted to ascertain which ORL1 receptor subtype was present in SG neurons. Following mRNA isolation and PCR amplification with primers (see Materials and Methods), the receptor was cloned. Figure 5 shows the nucleotide and deduced amino acid sequence of the cloned ORL1 receptor in SG neurons. Of the eight clones obtained, none contained the 84-base insertion described above. The boxed amino acid sequences represent putative transmembrane segments. This sequence corresponds to the short splice variant of the ORL1 receptor (Xie et al., 1999) . When compared with other deduced amino acid sequences derived from short splice variant forms isolated from rat brain (GenBank account nos. NM_031569, D16438, and U07871), there is a 100% homology. Thus, from these results, the long splice variant does not appear to be expressed in rat SG neurons.
Discussion
The series of aforementioned experiments explored the coupling mechanisms between the opioid ORL1 receptor and Ca 2ϩ channels in rat SG neurons. Administration of the endogenous ORL1 receptor ligand, Noc, has been reported to exert vasopressor effects. The cardiovascular actions produced by Noc are a result of the peptide's ability to modulate autonomic neurotransmission at several levels (Kapusta, 2000) . For instance, Noc can inhibit NE release in sympathetic neurons innervating blood vessels (Malinowska et al., 2000) , vas deferens (Bigoni et al., 1999) , and rat tail artery (Bucher, 1998) . In addition, the hypotensive and bradycardiac effects of Noc administration have been shown to correlate with decreases in plasma NE levels (Hashiba et al., 2003) . Finally, a recent report found that ORL1 receptors are present in rat sympathetic neurons innervating cardiac muscle (Malinowska et al., 2001 ). Since ORL1 receptors and N-type Ca 2ϩ channels have been found to form a physical complex (Beedle et al., 2004) , it was hypothesized that Noc- jpet.aspetjournals.org stimulated ORL1 receptors would modulate Ca 2ϩ channels in SG neurons. Thus, we took advantage of our ability to retrograde label SG neurons with a fluorescent tracer in a noninvasive manner to focus on the signaling mechanisms underlying the modulation of Ca 2ϩ channels by Noc-stimulated ORL1 receptors.
Our initial findings suggest that in acutely isolated SG neurons the three classic opioid receptors (, , and ␦) are not expressed in the soma. These results are supported by previous studies that reported opioid peptides modulate preganglionic rather than postganglionic nerve activity in rat (Mo et al., 1994) , cat (Prosdocimi et al., 1986) , and guinea pig (Ledda et al., 1984) SG neurons. Although these earlier studies did not focus on ion channel modulation, they provide evidence that suggests these opioid receptor subtypes do not modulate postganglionic transmission in SG neurons. An alternative explanation may be that stimulation of these receptors does not lead to N-type Ca 2ϩ channel modulation. Furthermore, studies need to be performed to explore this possibility.
The measured potency of the Noc-mediated Ca 2ϩ current inhibition in this study was comparable with the values reported by others in pyramidal neurons (Knoflach et al., 1996) and cultured cells (Morikawa et al., 1998) . However, the EC 50 value was greater than that found in periaqueductal gray neurons (Connor and Christie, 1998) , rat dorsal root ganglion (DRG) neurons (Beedle et al., 2004) , and nearly 200-fold higher in rat superior cervical ganglion (SCG) neurons (Larsson et al., 2000) . First, one possible reason for the discrepant findings between sympathetic SCG and SG neurons may be the rat strain employed. Wistar rats were used in the present study, whereas Sprague-Dawley rats were employed by Larsson et al. (2000) . Second, we recorded Ca 2ϩ currents from neurons that were incubated overnight following cell dissociation, whereas Larsson and colleagues measured Ca 2ϩ channel currents within 3 to 8 h of cell isolation. And third, differences in ORL1 receptor expression density between both neuron cell types may also account for these discrepancies. Finally, the difference in potency between the present study and that in rat DRG neurons (Beedle et al., 2004) may be a result of the ORL1 receptor splice variant expressed in each neuron type. For example, a recent molecular study (discussed below) found that ORL1 mRNA is present in both SCG and DRG (Xie et al., 1999) . However, expression of the long splice variant is dominant in the former, whereas expression of the shorter splice variant is greater in the latter.
In the present study, the signaling elements involved in coupling ORL1 receptors and Ca 2ϩ channels were also investigated. Because ORL1 receptors and opioid receptors, in general, are well established to couple to PTX-sensitive G␣ i/o protein subunits (New and Wong, 2002) , we found that Ca 2ϩ channel inhibition was significantly decreased in SG neurons pretreated with the toxin. Similar findings have been previously published (Morikawa et al., 1998; Connor et al., 1999; Larsson et al., 2000; Beedle et al., 2004; Yeon et al., 2004) . Nevertheless, it has been reported that ORL1 receptors are also capable of coupling to other PTX-insensitive G␣ protein subunits to modulate other effectors (Chan et al., 1998; Chan and Wong, 2000) .
In this study, the modulation of N-type Ca 2ϩ channel currents by Noc-stimulated receptors was further examined. The VD inhibition of Ca 2ϩ currents is membrane-delimited and mediated by the free G␤␥ dimers that are released following receptor stimulation (Herlitze et al., 1996; Ikeda, 1996) . Exposure of labeled neurons to Noc resulted in the VD inhibition of Ca 2ϩ currents, as observed by kinetic slowing and an increase in postpulse facilitation. Although it is not exactly clear how binding of G␤␥ is coupled to the activation machinery of N-type Ca 2ϩ channels, our observations also point to G␤␥ as the active moiety that modulates N-type Ca 2ϩ channels. These observations have been reported in other neurons and expression systems (Morikawa et al., jpet.aspetjournals.org 1998; Connor et al., 1999; Larsson et al., 2000; Beedle et al., 2004; Yeon et al., 2004) . In a more detailed study of Noc's modulation of Ca 2ϩ channels, evidence has been presented to indicate that ORL1 receptors form a physical signaling complex with N-type Ca 2ϩ channels that results in tonic VD inhibition (Beedle et al., 2004) . In that report, it was shown that the agonist-independent, tonic VD inhibition of N-type Ca 2ϩ channels occurred in both rat DRG neurons and tsa-201-transfected cells. The tonic inhibition was more noticeable in small DRG than in large DRG neurons (Beedle et al., 2004) .
Pharmacological studies employing ORL1-opioid receptor chimeras have shown that the second extracellular loop plays an essential role in ORL1 receptor binding and activation (Mollereau et al., 1999; New and Wong, 2002) . Previous reports have shown that at least two ORL1 opioid receptor splice variants (long and short) are present in rats (Wang et al., 1994; Xie et al., 1999) . The long splice variant contains an additional 84-base pair sequence (28 amino acids) that codes for an N-linked glycosylation sequence in the second extracellular loop. Currently, expression or functional data exploring the consequence of this additional sequence is not available and needs to be further examined. Interestingly, Xie and colleagues (1999) found that the ratio of long to short splice variant expression, as measured by mRNA levels, in rat sympathetic lumbar and SCG neurons was approximately 5:1. More recent studies indicate the existence of several additional splice variants (Curro et al., 2001 ) and an 81-base insertion in the second extracellular loop due to retention of intron 3 (Xie et al., 2000) . This retained intron is in the same location as the 84-base insertion mentioned above but leads to an inframe stop resulting in a truncated receptor protein.
However, in the present study, only the short splice variant was detected in mRNA samples isolated from SG neurons. Thus, it appears that ORL1 receptor expression in rat peripheral sympathetic neurons may occur in a differential manner and may also help explain the differences in N-type Ca 2ϩ channel modulation between SG and SCG (Larsson et al., 2000) or DRG neurons (Beedle et al., 2004) indicated above.
Recent observations by Malinowska and colleagues (Malinowska et al., 2000 have shown that intravenous exposure of Noc in anesthetized rats led to a decrease in blood pressure and heart rate. As ORL1 receptors are expressed in central and peripheral nervous systems, the Noc-induced effects likely occur at several levels. For instance, Noc has been shown to inhibit the inotropic response produced by electrically evoked NE release from sympathetic nerve endings in the guinea pig isolated atrium . Thus, the findings of the present study further aid in elucidating some of the underlying mechanisms that are involved in the regulation of the cardiovascular system following Noc administration. This study focused on SG neurons, the sympathetic input to cardiac muscle. These findings suggest that the Nocinduced hypotension and bradycardia, observed by others Malinowska et al., 2001) , is the result of neurotransmitter release modulation via N-type Ca 2ϩ channel inhibition in SG neurons. Therefore, the presence of ORL1 receptors in SG neurons likely regulate Noc-induced cardiac inotropism.
In summary, our results show that sympathetic SG neurons innervating cardiac muscle express ORL1 receptors that modulate N-type Ca 2ϩ channels following exposure to Noc. The ORL1 receptor-Ca 2ϩ channel coupling mechanism is PTX-sensitive and blocked by the UFP-101 compound. Moreover, the inhibition of N-type Ca 2ϩ channels is VD and membrane-delimited. Cloning experiments of the ORL1 receptor revealed one receptor subtype or one splice variant in adult rats.
